Abstract
Background
Genetic variants in hormone receptor genes may be crucial predisposing factors for breast cancer, and microsatellites in the androgen receptor gene (AR) have been suggested to play a role. The aim of the study was to determine the association between the length of the CAG repeats in the AR gene and the development of breast cancer. Methodology: In total, 75 breast cancer cases and 50 healthy controls were analyzed for CAG repeats in the AR gene by polymerase chain reaction and the GeneScan/Genotyping technique.
Results
CAG repeat genotypes and alleles distribution were found to be significantly different between breast cancer patients and controls (P < 0.05). While the presence of CAG repeats shorter than 22 (classified as short, S) increases the risk of breast cancer, the risk is reduced by the presence of CAG repeats longer than 22. In the group of patients with breast cancer, a high tumor stage was found to have a significant association with genotype S/S of CAG repeats in the AR gene.
Conclusion
Our results suggest that the length of CAG repeats in the androgen receptor gene is associated with the risk of developing breast cancer.
Similar content being viewed by others
References
Wojciechowska U., Didkowska J., Zatoński W., Cancer in Poland in 2010. Centrum Onkologii-Instytut im. M. Skłodowskiej-Curie, Warszawa, 2012
Hickey T.E., Robinson J.L., Carroll J.S., Tilley W.D., Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?, Mol. Endocrinol., 2012, 26, 1252–1267
Kotsopoulos J., Narod S.A., Androgens and breast cancer, Steroids, 2012, 77, 1–9
Hu R., Dawood S., Holmes M.D., Collins L.C., Schnitt S.J., Cole K., et al., Androgen receptor expression and breast cancer survival in postmenopausal women, Clin. Cancer Res., 2011, 17, 1867–1874
Gonzalez L.O., Corte M.D., Vazquez J., Junquera S., Sanchez R., Alvarez A.C., et al., Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors, BMC Cancer, 2008, 8, 149
Bryś M., Wójcik M., Romanowicz-Makowka H., Krajewska W.M., Androgen receptor status in female breast cancer: RT-PCR and Western blot studies, J. Cancer Res. Clin. Oncol., 2002, 128, 85–90
Bryś M., Androgens and androgen receptor: do they play a role in breast cancer?, Med. Sci. Monit., 2000, 6, 433–438
Nowacka-Zawisza M., Krajewska W.M., Triplenegative breast cancer: molecular characteristics and potential therapeutic approaches, Adv. Hyg. Exp. Med. (in Polish) (Online), 2013, 67, 1090–1097
Gucalp A., Traina T.A., Triple-negative breast cancer: role of the androgen receptor, Cancer J., 2010, 16, 62–65
Park S, Koo J., Park H.S., Kim J.H., Choi S.Y., Lee J.H., et al., Expression of androgen receptors in primary breast cancer. Ann. Oncol., 2010, 21, 488–492
Ryan C.P., Crespi B.J., Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility, Evol. Appl., 2013, 6, 180–196
Zhang T., Liang W., Fang M., Yu J., Ni Y., Li Z., Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis, Gene, 2013, 524, 161–167
Kumar R., Atamna H., Zakharov M.N., Bhasin S., Khan S.H., Jasuja R., Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy, Life Sci., 2011, 88, 565–571
Palazzolo I., Gliozzi A., Rusmini P., Sau D., Crippa V., Simonini F., et al., The role of the polyglutamine tract in androgen receptor, J. Steroid Biochem. Mol. Biol., 2008, 108, 245–253
Zheng Y., Huo D., Zhang J., Yoshimatsu T.F., Niu Q., Olopade O.I., Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women, PLoS One, 2012, 7, e40494
Rajender S., Francis A., Pooja S., Krupakar N., Surekha D., Reddy G., et al., CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world, Breast Cancer Res. Treat., 2011, 127, 751–760
Chintamani, Kulshreshtha P., Chakraborty A., Singh L., Mishra A.K., Bhatnagar D., et al., Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women, World J. Surg. Oncol., 2010, 8: 64
Slattery M.L., Sweeney C., Herrick J., Wolff R., Baumgartner K., Giuliano A., et al., ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States, Breast Cancer Res. Treat., 2007, 105, 327–35
Wedrén S., Magnusson C., Humphreys K., Melhus H., Kindmark A., Stiger F., et al., Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer, Cancer Epidemiol Biomarkers Prev., 2007, 16, 1775–1783
Cox D.G., Blanché H., Pearce C.L., Calle E.E., Colditz G.A., Pike M.C., et al., A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3), Breast Cancer Res., 2006, 8, R54
Spurdle A.B., Antoniou A.C., Duffy D.L., Pandeya N., Kelemen L., Chen X., et al., The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers, Breast Cancer Res., 2004, 7, R176–183
Syrjakäski K., Hyytinen E.R., Kuukasjärvi T., Auvinen A., Kallioniemi O.P., Kainu T, et al., Androgen receptor gene alterations in Finnish male breast cancer, Breast Cancer Res. Treat., 2003, 77, 167–170
Haiman C.A., Brown M., Hankinson S.E., Spiegelman D., Colditz G.A., Willett W.C., et al., The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses’ Health Study, Cancer Res., 2002, 62, 1045–1049
Kristiansen M., Langerod A., Knudsen G.P., Weber B.L., Borresen-Dale A.L., Orstavik K.H., High frequency of skewed X inactivation in young breast cancer patients, J. Med. Genet, 2002, 39, 30–33
Kadouri L., Easton D.F., Edwards S., Hubert A., Kote-Jarai Z., Glaser B., et al., CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers, Br. J. Cancer, 2001, 85, 36–40
Menin C., Banna G.L., De Salvo G., Lazzarotto V., De Nicolo A., Agata S., et al., Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer, Cancer Lett., 2001, 168, 31–36
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk, Abbas S., Beckmann L., Chang-Claude J., Hein R., Kropp S., Parthimos M., et al., Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy, Int. J. Cancer, 2010, 126, 2935–2946
Dagan E., Friedman E., Paperna T., Carmi N., Gershoni-Baruch R., Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype, Eur. J. Hum. Genet., 2002, 10, 724–728
Giguère Y., Dewailly E., Brisson J., Ayotte P., Laflamme N., Demers A., et al., Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population, Cancer Res., 2001, 61, 5869–5874
Mehdipour P., Pirouzpanah S., Kheirollahi M., Atri M., Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study, Breast J., 2010, 17, 39–46
Sakoda L.C., Blackston C.R., Doherty J.A., Ray R.M., Lin M.G., Gao D.L., et al., Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women, Cancer Epidemiol., 2010, 35, 48–55
Tsezou A., Tzetis M., Gennatas C., Giannatou E., Pampanos A., Malamis G., et al., Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer, Breast, 2008, 17, 159–166
Wu M.H., Chou Y.C., Yu C.P., Yang T., You S.L., Chen C.J., et al., Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility, Eur. J. Cancer Prev., 2008, 17, 317–322
González A., Javier Dorta F., Rodriguez G., Brito B., Rodríguez M.A., Cabrera A., et al., Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene, Eur. J. Cancer, 2007, 43, 2373–2380
Anghel A., Raica M., Marian C., Ursoniu S., Mitrasca O., Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer, J. Cancer Res. Clin. Oncol., 2006, 132, 727–733
Suter N.M., Malone K.E., Daling J.R., Doody D.R., Ostrander E.A., Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women, Cancer Epidemiol. Biomarkers Prev., 2003, 12, 127–135
Elhaji Y.A., Gottlieb B., Lumbroso R., Beitel L.K., Foulkes W.D., Pinsky L., et al. The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40, Breast Cancer Res. Treat., 2001, 70, 109–116
Yu H., Bharaj B., Vassilikos E.J., Giai M., Diamandis E.P., Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer, Breast Cancer Res. Treat., 2000, 59, 153–161
Hao Y., Montiel R., Li B., Huang E., Zeng L., Huang Y., Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis, Breast Cancer Res. Treat., 2010, 124, 815–820
Kaaks R., Rinaldi S., Key T.J, Berrino F., Peeters P.H., Biessy C., et al., Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition, Endocr. Relat. Cancer, 2005, 12, 1071–1082
Wang W., John E.M., Ingles S.A., Androgen receptor and prostate-specific antigen gene polymorphisms and breast cancer in African-American women, Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2990–2994
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nowacka-Zawisza, M., Forma, E., Urbańska, A. et al. The CAG repeat polymorphism of the androgen receptor gene and breast cancer. cent.eur.j.biol. 9, 833–840 (2014). https://doi.org/10.2478/s11535-014-0325-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-014-0325-y